Clinical bottom line
The increasing prevalence of vaping among adolescents has raised significant concerns regarding its impact on lung health and disease progression. Current evidence suggests that vaping can lead to both acute and chronic respiratory effects, potentially exacerbating pre-existing conditions and contributing to the development of new pulmonary issues. Clinicians should be aware of these risks and consider them when evaluating respiratory symptoms in adolescents.
What the evidence shows
Recent studies have highlighted several potential health risks associated with vaping in adolescents. A systematic review by Gotts et al. (2019) indicates that e-cigarette use can cause acute lung injury and inflammation, similar to that observed with traditional tobacco smoking (PMID: 31373237). Furthermore, a study by Layden et al. (2020) documented cases of e-cigarette or vaping product use-associated lung injury (EVALI), characterized by symptoms such as cough, shortness of breath, and chest pain (PMID: 31633830).
In addition to acute effects, there is growing evidence of long-term respiratory consequences. A longitudinal study by Bhatta and Glantz (2020) found that e-cigarette use is associated with an increased risk of chronic bronchitis symptoms and asthma exacerbations in adolescents (PMID: 31983254). This suggests that vaping may contribute to the progression of chronic respiratory diseases.
Caveats and uncertainty
While the evidence points to significant risks, there are several caveats and uncertainties. Many studies rely on self-reported data, which may introduce bias and affect the accuracy of findings. Additionally, the long-term health effects of vaping are still not fully understood, as e-cigarettes have only been widely used for a relatively short period. The diversity of e-cigarette products and the variability in their chemical compositions further complicate the assessment of health risks.
Moreover, the potential benefits of e-cigarettes as smoking cessation tools for adults should not be overlooked. However, this potential does not negate the specific risks posed to adolescents, a population for whom vaping is not intended.
How this may change practice
Clinicians should incorporate questions about e-cigarette use into routine assessments of adolescent patients, particularly those presenting with respiratory symptoms. Awareness of the potential risks associated with vaping can guide diagnostic considerations and inform discussions with patients and their families about the dangers of e-cigarette use. Additionally, healthcare providers should advocate for preventive measures, such as educational programs and policy interventions, to reduce vaping among adolescents.